| Literature DB >> 31780195 |
Maya Korem1, Yuval Geffen2, Sharon Amit3.
Abstract
A modification of fluconazole formulation in the VITEK2 AST-YS08 card revoked the fluconazole-Candida glabrata combination. An evaluation of AST-YS08 following C. glabrata to C. albicans adjustment within VITEK2 software revealed higher fluconazole MICs compared to AST-YS07 and E-test, with major discrepancies. This mandates an alternative approach to fluconazole-C. glabrata susceptibility testing.Entities:
Keywords: AST-YS08 card; Candida glabrata; Susceptibility testing; VITEK2
Mesh:
Substances:
Year: 2019 PMID: 31780195 DOI: 10.1016/j.diagmicrobio.2019.114896
Source DB: PubMed Journal: Diagn Microbiol Infect Dis ISSN: 0732-8893 Impact factor: 2.803